Dr. Mittendorf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Avenue
Boston, MA 02215Phone+1 617-582-9277
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2005 - 2008
- Case Western Reserve University School of MedicineClass of 1996
Certifications & Licensure
- MA State Medical License 2017 - 2025
- TX State Medical License 2005 - 2019
- OH State Medical License 1997 - 2008
- American Board of Surgery Surgery
Clinical Trials
- Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA) Start of enrollment: 2020 Jul 02
Publications & Presentations
PubMed
- Risk of Surgical Overtreatment in cN1 Breast Cancer Patients who Become ypN0 After Neoadjuvant Chemotherapy: SLNB Versus TAD.Alison Laws, Saskia Leonard, Julie Vincuilla, Tonia Parker, Olga Kantor
Annals of Surgical Oncology. 2024-12-04 - 1 citationsQuality control for single-cell analysis of high-plex tissue profiles using CyLinter.Gregory J Baker, Edward Novikov, Ziyuan Zhao, Tuulia Vallius, Janae A Davis
Nature Methods. 2024-12-01 - Real-World Implications of the SOUND Trial.Andreas Giannakou, Olga Kantor, Ko Un Park, Adrienne G Waks, Rinaa S Punglia
Annals of Surgical Oncology. 2024-12-01
Press Mentions
- When or Whether to Give Immunotherapy in Early Breast CancerNovember 19th, 2024
- Researchers Analyse the Efficacy of Immunotherapy Combined with Chemotherapy in the Treatment of Early Breast CancerSeptember 30th, 2024
- Benefits of Neoadjuvant Immunotherapy in Breast Cancer Extend Beyond TNBCAugust 29th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: